ABBOTT LABORATORIES Total Assets

• ABBOTT LABORATORIES showed an increase of +6.5% in Total Assets from 2024 to 2025.
• This data is from ABBOTT LABORATORIES's annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2009: $47.63 billion | Q3 2009: $49.85 billion | Q1 2010: $53.36 billion | Q2 2010: $53.38 billion | Q3 2010: $57.37 billion | Q1 2011: $61.65 billion | Q2 2011: $62.00 billion | Q3 2011: $59.63 billion | Q1 2012: $62.42 billion | Q2 2012: $61.86 billion | Q3 2012: $63.26 billion | Q1 2013: $42.69 billion | Q2 2013: $42.90 billion | Q3 2013: $44.13 billion | Q1 2014: $41.66 billion | Q2 2014: $41.48 billion | Q3 2014: $42.51 billion | Q1 2015: $43.10 billion | Q2 2015: $44.13 billion | Q3 2015: $41.73 billion | Q1 2016: $39.64 billion | Q2 2016: $39.83 billion | Q3 2016: $39.50 billion | Q1 2017: $70.89 billion | Q2 2017: $71.15 billion | Q3 2017: $72.25 billion | Q1 2018: $70.91 billion | Q2 2018: $68.42 billion | Q3 2018: $71.64 billion | Q1 2019: $67.61 billion | Q2 2019: $68.43 billion | Q3 2019: $68.54 billion | Q1 2020: $66.78 billion | Q2 2020: $68.78 billion | Q3 2020: $69.04 billion | Q1 2021: $72.79 billion | Q2 2021: $73.27 billion | Q3 2021: $73.80 billion | Q1 2022: $74.01 billion | Q2 2022: $74.20 billion | Q3 2022: $72.80 billion | Q1 2023: $73.79 billion | Q2 2023: $73.35 billion | Q3 2023: $72.09 billion | Q1 2024: $72.47 billion | Q2 2024: $73.02 billion | Q3 2024: $74.36 billion | Q1 2025: $81.45 billion | Q2 2025: $84.00 billion | Q3 2025: $84.18 billion.
• Over the full 19 years of available data (2007 to 2025), ABBOTT LABORATORIES's Total Assets has grown by 118.3%.
• Historical annual values: Fiscal year 2025: $86.71 billion | Fiscal year 2024: $81.41 billion | Fiscal year 2023: $73.21 billion | Fiscal year 2022: $74.44 billion | Fiscal year 2021: $75.20 billion | Fiscal year 2020: $72.55 billion | Fiscal year 2019: $67.89 billion | Fiscal year 2018: $67.17 billion | Fiscal year 2017: $76.25 billion | Fiscal year 2016: $52.67 billion | Fiscal year 2015: $41.25 billion | Fiscal year 2014: $41.21 billion | Fiscal year 2013: $42.94 billion | Fiscal year 2012: $67.24 billion | Fiscal year 2011: $60.28 billion | Fiscal year 2010: $60.57 billion | Fiscal year 2009: $52.58 billion | Fiscal year 2008: $42.42 billion | Fiscal year 2007: $39.71 billion.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026